AZTherapies is a series c plus startup based in United States. 1 investor tracked.
AZTherapies is a company headquartered in the Netherlands. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
AZTherapies is a biopharmaceutical company focused on developing innovative therapies to treat neurodegenerative diseases such as Alzheimer's, ALS, and Parkinson's by targeting neuroinflammation as a root cause.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.